The emerging therapy of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment